Abstract Objective To study the mRNA level of runt-related transcription factor 3 (RUNX3) in children with bronchiolitis and its clinical significance in bronchiolitis. Methods A total of 54 young children with bronchiolitis were enrolled as the bronchiolitis group, among whom 28 with atopic constitution were enrolled in the atopic bronchiolitis group and 26 with non-atopic constitution were enrolled in the non-atopic bronchiolitis group. A total of 48 healthy young children were enrolled as the healthy control group, among whom 24 with atopic constitution were enrolled in the atopic healthy control group and 24 with non-atopic constitution were enrolled in the non-atopic healthy control group. Quantitative real-time PCR was used to measure the mRNA level of RUNX3 in peripheral blood mononuclear cells. ELISA was used to measure the serum levels of interleukin-4 (IL-4) and interferon gamma (IFN-γ). Results The bronchiolitis group had a significantly lower mRNA level of RUNX3 than the healthy control group, and the atopic bronchiolitis group had a significantly lower mRNA level of RUNX3 than the non-atopic bronchiolitis, atopic healthy control, and non-atopic healthy control groups (P < 0.05). The bronchiolitis group had a significantly higher serum level of IL-4 than the healthy control group, and the atopic bronchiolitis group had a significantly higher serum level of IL-4 than the non-atopic healthy control group (P < 0.05). The bronchiolitis group had a significantly lower serum level of IFN-γ than the healthy control group, and the atopic bronchiolitis group had a significantly lower serum level of IFN-γ than the non-atopic bronchiolitis, atopic healthy control, and non-atopic healthy control groups (P < 0.05). The correlation analysis showed that the mRNA level of RUNX3 was negatively correlated with the serum level of IL-4 and was positively correlated with the serum level of IFN-γ (P < 0.05). Conclusions Measurement of RUNX3 gene expression in peripheral blood mononuclear cells has a certain value in identifying children with atopic constitution at high risk of asthma among children with bronchiolitis.
MEN Shuai,YU Yan-Yan,ZHANG Yu-Hong et al. Expression and clinical significance of runt-related transcription factor 3 in children with bronchiolitis[J]. CJCP, 2019, 21(10): 1005-1011.
MEN Shuai,YU Yan-Yan,ZHANG Yu-Hong et al. Expression and clinical significance of runt-related transcription factor 3 in children with bronchiolitis[J]. CJCP, 2019, 21(10): 1005-1011.
Xiong Y, Castro E, Yagi R, et al. Thpok-independent repression of Runx3 by Gata3 during CD4+T-cell differentiation in the thymus[J]. Eur J Immunol, 2013, 43(4):918-928.
[2]
Diao M, Min J, Guo F, et al. Effects of salbutamol aerosol combined with magnesium sulfate on T-lymphocyte subgroup and Th1/Th2 cytokines of pediatric asthma[J]. Exp Ther Med, 2017, 13(1):117-120.
[3]
Fan L, Wang X, Fan L, et al. MicroRNA-145 influences the balance of Th1/Th2 via regulating RUNX3 in asthma patients[J]. Exp Lung Res, 2016, 42(8-10):417-424.
[4]
Tanriver Y, Diefenbach A. Transcription factors controlling development and function of innate lymphoid cells[J]. Int Immunol, 2014, 26(3):119-128.
[5]
Ferrini ME, Hong S, Stierle A, et al. CB2 receptors regulate natural killer cells that limit allergic airway inflammation in a murine model of asthma[J]. Allergy, 2017, 72(6):937-947.
[6]
Barnig C, Cernadas M, Dutile S, et al. Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma[J]. Sci Transl Med, 2013, 5(174):174ra26.
[7]
Lambrecht BN, Hammad H. The immunology of asthma[J]. Nat Immunol, 2014, 16(1):45-56.
[8]
Hong JY, Bentley JK, Chung Y, et al. Neonatal rhinovirus induces mucous metaplasia and airways hyperresponsiveness through IL-25 and type 2 innate lymphoid cells[J]. J Allergy Clin Immunol, 2014, 134(2):429-439.
Xue M, Chen LY, Wang WJ, et al. HOTAIR induces the ubiquitination of Runx3 by interacting with Mex3b and enhances the invasion of gastric cancer cells[J]. Gastric Cancer, 2018, 21(5):756-764.
[12]
Kang KA, Piao MJ, Ryu YS, et al. Cytoplasmic localization of RUNX3 via histone deacetylase-mediated SRC expression in oxidative-stressed colon cancer cells[J]. J Cell Physiol, 2017, 232(7):1914-1921.
[13]
Yang H, Fu J, Yao L, et al. RUNX3 is a key modulator during the epithelial-mesenchymal transition of alveolar type Ⅱ cells in animal models of BPD[J]. Int J Mol Med, 2017, 40(5):1466-1476.
[14]
Guo C, Ahmad T, Beckly J, et al. Association of caspase-9 and RUNX3 with inflammatory bowel disease[J]. Tissue Antigens, 2011, 77(1):23-29.
[15]
Fainaru O, Shseyov D, Hantisteanu S, et al. Accelerated chemokine receptor 7-mediated dendritic cell migration in Runx3 knockout mice and the spontaneous development of asthma-like disease[J]. Proc Natl Acad Sci U S A, 2005, 102(30):10598-10603.
[16]
Fainaru O, Woolf E, Lotem J, et al. Runx3 regulates mouse TGF-β-mediated dendritic cell function and its absence results in airway inflammation[J]. EMBO J, 2014, 23(4):969-979.
[17]
Pawelczyk M, Kowalski ML. The role of human parainfluenza virus infections in the immunopathology of the respiratory tract[J]. Curr Allergy Asthma Rep, 2017, 17(3):16.
Wu Q, Tang Y, Hu X, et al. Regulation of Th1/Th2 balance through OX40/OX40L signalling by glycyrrhizic acid in a murine model of asthma[J]. Respirology, 2016, 21(1):102-111.
[20]
Russell CD, Unger SA, Walton M, et al. The human immune response to respiratory syncytial virus infection[J]. Clin Microbiol Rev, 2017, 2(30):481-502.
[21]
Fonseca W, Lucey K, Jang S, et al. Lactobacillus johnsonii supplementation attenuates respiratory viral infection via metabolic reprogramming and immune cell modulation[J]. Mucosal immunol, 2017:10(6):1569-1580.
[22]
Fedele G, Schiavoni I, Nenna R, et al. Analysis of the immune response in infants hospitalized with viral bronchiolitis shows different Th1/Th2 profiles associated with respiratory syncytial virus and human rhinovirus[J]. Pediatr Allergy Immunol, 2018, 29(5):555-557.
Clark RA. Resident memory T cells:Runx and hide[J]. Sci Immunol, 2018, 3(19). pii:eaar5172.
[25]
Shan Q, Zeng Z, Xing S, et al. The transcription factor RUNX3 guards cytotoxic CD8+effector T cells against deviation towards follicular helper T cell lineage[J]. Nat Immunol, 2017, 18(8):931-939.
[26]
Serroukh Y, Gu-Trantien C, Hooshiar Kashani B, et al. The transcription factors Runx3 and ThPOK cross-regulate acquisition of cytotoxic function by human Th1 lymphocytes[J]. Elife, 2018, 7. pii:e30496.
[27]
Kim B, Sasaki Y, Egawa T. Restriction of nonpermissive RUNX3 protein expression in T lymphocytes by the kozak sequence[J]. J Immunol, 2015, 195(4):1517-1523.
[28]
Wang Y, Godec J, Ben-Aissa K, et al. The transcription factors T-bet and Runx are required for the ontogeny of pathogenic interferon-γ-producing T helper 17 cells[J]. Immunity, 2014, 40(3):355-366.
[29]
Qiu YY, Zhang YW, Qian XF, et al. miR-371, miR-138, miR-544, miR-145, and miR-214 could modulate Th1/Th2 balance in asthma through the combinatorial regulation of RUNX3[J]. Am J Transl Res, 2017, 9(7):3184-3199.
